Virios Therapeutics Inc

NASDAQ:VIRI  
5.02
+0.07 (+1.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Virios Therapeutics Inc Stock, NASDAQ:VIRI

44 Milton Avenue, Alpharetta, Georgia 30009
United States of America
Phone: +1.866.620.8655
Number of Employees: 3

Description

Virios Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1 a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.